Comparison

Borofalan European Partner

Item no. HY-129812-50mg
Manufacturer MedChem Express
CASRN 80994-59-8
Amount 50 mg
Quantity options 100 mg 10 mg 1 ea 1 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.59
Formula C9H12 10BNO4
Citations [1]Hirose K, et al. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial. Radiother Oncol. 2021 Feb;155:182-187.
Smiles OC([C@@H](N)CC1=CC=C(C=C1)[10B](O)O)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping condition Cool pack
Available
Manufacturer - Type
Isotope-Labeled Compounds
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Isotope-Labeled Compounds
Shipping Temperature
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Molecular Weight
208.21
Product Description
Borofalan- 10 B can be used for Boron neutron capture research (BNCT). Borofalan- 10 B can be used for the research of recurrent or locally advanced head and neck cancer [1] [2] [3] .
Manufacturer - Research Area
Cancer
Solubility
H2O : 4 mg/mL (ultrasonic; warming; adjust pH to 11 with NaOH; heat to 70°C)
Manufacturer - Pathway
Others
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: Out of stock
Questions about this Product?
 
Close